Pharmaceutical Executive company information, Employees & Contact Information

Novartis Enters $12 Billion Definitive Merger Agreement to Acquire Avidity Biosciences Pharmaceutical Executive

TrumpRx's Implication on DTC Commercialization | PharmExec Pharmaceutical Executive

Novo Nordisk's Shares Fall After Board Shake-Up | PharmExec Pharmaceutical Executive

Ypsomed Announces New U.S.-Based Manufacturing Site in North Carolina | PharmExec Pharmaceutical Executive

Novo Nordisk's Board Shake-Up | PharmExec Pharmaceutical Executive

Takeda and Innovent Biologics Announce Strategic Global Partnership Pharmaceutical Executive

2025 Pharm Exec Top 50 Companies Pharmaceutical Executive

How Will TrumpRx Impact Manufacturer-Produced DTC Programs? Pharmaceutical Executive

Merck's $70 Billion Investment | PharmExec Pharmaceutical Executive

Rethinking Workforce Development | PharmExec Pharmaceutical Executive

FDA's National Priority Voucher Program | PharmExec Pharmaceutical Executive

Direct-To-Consumer Trends | PharmExec Pharmaceutical Executive

Policy Whiplash | PharmExec Pharmaceutical Executive

Jazz Pharmaceuticals & Saniona Enter an Exclusive Licensing Agreement to Develop and Commercialize SAN2355 Pharmaceutical Executive

AbbVie Expands Psychiatry Drug Pipeline with Acquisition of Gilgamesh Pharmaceuticals’ Bretisilocin for Major Depressive Disorder Pharmaceutical Executive

EMD Serono’s Agreement with US Government Pharmaceutical Executive

Superluminal Medicines and Eli Lilly Form $1.3 Billion Collaboration Advancing Small Molecule Therapeutics Pharmaceutical Executive

Preventing Suffering Through Access: A Strategic Imperative for Global Pharmaceutical Growth Pharmaceutical Executive

Why Every Pharma Executive Should Be Watching the Regeneron Kickback Case Pharmaceutical Executive

Amgen Launches New Direct-To-Consumer Platform | PharmExec Pharmaceutical Executive

Eli Lilly’s Orforglipron Successfully Completes Third Phase 3 Trial Resulting in Global Regulatory Submissions Pharmaceutical Executive

President Trump Announces Most-Favored-Nation Policy for Pharma Prices Pharmaceutical Executive

Enlaza Therapeutics Forms $2.4 Billion Collaboration with Vertex Pharmaceuticals Pharmaceutical Executive

Updated Vaccine Recommendations | PharmExec Pharmaceutical Executive

XOMA Royalty Subsidiary to Acquire Mural Oncology in Premium Cash Transaction Pharmaceutical Executive

FDA Lifts Clinical Hold on NUZ-001 | PharmExec Pharmaceutical Executive

Skyhawk Therapeutics, Merck KGaA Strike Multi-Billion Dollar Deal to Advance RNA Therapies in Neurology Pharmaceutical Executive

The Reality of AI: Q&A with Shweta Maniar Pharmaceutical Executive

Novo Nordisk to Cut 9,000 Jobs in Global Restructuring Effort Pharmaceutical Executive

Vinay Prasad’s FDA Departure Follows Controversy Over Drug Rejections Pharmaceutical Executive

President Trump Issues Letters to 17 Major Pharma Companies Demanding Action on Most-Favored-Nation Order Pharmaceutical Executive

FDA Approves Ionis Pharmaceuticals’ Dawnzera for Hereditary Angioedema Pharmaceutical Executive

Bayer Extends Partnership with Tsinghua University in China to Accelerate Drug Discovery Pharmaceutical Executive

Trump: 'Major Tariff' on Pharmaceuticals Coming Soon Pharmaceutical Executive

Texas Sues Eli Lilly for Allegedly Bribing Providers to Prescribe Drugs Pharmaceutical Executive

FDA's new Fast-Track Review | PharmExec Pharmaceutical Executive

Merck KGaA Completes Acquisition of SpringWorks Therapeutics in $3.4 Billion Deal Pharmaceutical Executive

XtalPi and DoveTree Announce $6 Billion Collaboration for AI Drug Discovery Pharmaceutical Executive

September 5, 2025 | PharmExec Pharmaceutical Executive

President Trump Announces 100% Tariffs on Branded or Patented Pharmaceuticals Pharmaceutical Executive

Merck to Cut 6,000 Jobs as It Aims for $3 Billion in Cost Savings by 2027 Pharmaceutical Executive

How Unified Platforms are Reshaping Clinical Trial Economics Pharmaceutical Executive

Transforming Life Sciences R&D: The Business Case for AI Pharmaceutical Executive

September 9, 2025 | PharmExec Pharmaceutical Executive

President Trump Pauses Tariff Plan | PharmExec Pharmaceutical Executive

DeepL Announces HIPAA-Compliant AI Pharmaceutical Executive

September 8, 2025 | PharmExec Pharmaceutical Executive

Trump Pauses Plans to Impose 100% Tariffs on Pharma: Report Pharmaceutical Executive

September 25, 2025 | PharmExec Pharmaceutical Executive

Health Experts React to HHS mRNA Funding Cuts Pharmaceutical Executive

September 3, 2025 | PharmExec Pharmaceutical Executive

September 12, 2025 | PharmExec Pharmaceutical Executive

Zifo Survey Shows Biopharma Racing Toward AI Despite Data Management Challenges Pharmaceutical Executive

September 26, 2025 | PharmExec Pharmaceutical Executive

What the President’s Drug Pricing Push Means for Pharma, Payers, and Patients Pharmaceutical Executive

Navigating Funding Cuts and Unpredictable Tariffs: Q&A with Darius Lakdawalla, PhD Pharmaceutical Executive

September 11, 2025 | PharmExec Pharmaceutical Executive

September 29, 2025 | PharmExec Pharmaceutical Executive

September 16, 2025 | PharmExec Pharmaceutical Executive

TrumpRx Revealed | PharmExec Pharmaceutical Executive

September 15, 2025 | PharmExec Pharmaceutical Executive

Eli Lilly to Acquire Verve Therapeutics for $1 Billion Pharmaceutical Executive

Novo Nordisk Resubmits BLA for Awiqli | PharmExec Pharmaceutical Executive

Pharma Tariffs Announcement Still Weeks Away, New Report Says Pharmaceutical Executive

September 22, 2025 | PharmExec Pharmaceutical Executive

Pharma Industry Execs React to President Trump’s 60-Day MFN Deadline Pharmaceutical Executive

How Does the Shift to Early-Stage M&A Change Due Diligence? Pharmaceutical Executive

Viking Therapeutics, CordenPharma Strike Multi-Year Deal to Commercialize VK2735 for Obesity, Metabolic Disorders Pharmaceutical Executive

Lilly Bolsters ALS Pipeline Through $415 Million Licensing Agreement with Alchemab Therapeutics Pharmaceutical Executive

Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support Pharmaceutical Executive

AI Built for Pharma: Why Out-of-the-Box Beats Build-From-Scratch Pharmaceutical Executive

Capital Allocation is Strategy: Five Imperatives for Biopharma Leaders Pharmaceutical Executive

September 4, 2025 | PharmExec Pharmaceutical Executive

How AI is Shaping KOL and DOL Identification Pharmaceutical Executive

Reinventing Pharma Sales Force Effectiveness Pharmaceutical Executive

Pharm Exec's 2025 State of the Industry Survey Pharmaceutical Executive

Novartis Acquiring Tourmaline Bio for Cardiovascular Disease Treatment Pacibekitug Pharmaceutical Executive

China’s Trial Advantage: Tracking Nation’s Growth in Pharma Innovation and Global Investment Pharmaceutical Executive

Eli Lilly Announces 170% Price Increase for Mounjaro in UK Pharmaceutical Executive

Bayer Layoffs Reach 12,000 in Ongoing $2.3 Billion Restructuring Plan Pharmaceutical Executive

MAHA Draft Document Leaks, According to New Report Pharmaceutical Executive

Applying Porter’s Five Forces to Portfolio Management in Pharmaceutical R&D: A Strategic Roadmap Pharmaceutical Executive

White House Unveils Pharma Most-Favored-Nation Executive Order Pharmaceutical Executive

Teva’s Ajovy Maintains Long-Term Effectiveness in Preventing Chronic, Episodic Migraine Pharmaceutical Executive

Roche Invests $700 Million in North Carolina Facility to Advance Obesity Drug Manufacturing Pharmaceutical Executive

Merck To Acquire Verona Pharma and Expand its COPD Treatment Pipeline Pharmaceutical Executive

Beyond Approval: Why Your Oncology Label Determines Commercial Success Pharmaceutical Executive

Pharmaceutical Industry Faces Legal Uncertainty Over MFN Executive Order Pharmaceutical Executive

Unique Challenges in Repurposing Drugs for Addiction Treatment Pharmaceutical Executive

$25B Potential in Accelerating AI’s Impact and Value in Pharma Pharmaceutical Executive

Guiding Pharma Through Geopolitical Uncertainty: Q&A with the Federated Healthcare Advisory Panel Pharmaceutical Executive

Jazz Pharmaceuticals Appoints Renee Gala as CEO Pharmaceutical Executive

The Three Pillars of Pharma’s New Commercial Model Pharmaceutical Executive

GSK Gains $370 Million Upfront, Reduced Royalties in CureVac mRNA Patent Settlement Agreement with Pfizer, BioNTech Pharmaceutical Executive

FDA Approves Merck’s Enflonsia to Prevent Respiratory Syncytial Virus Pharmaceutical Executive

Layoffs Continue Across Biotech Industry as More Companies Restructure and Reprioritize Pharmaceutical Executive

Challenges to Navigating the Pharmaceutical Regulatory Landscape Pharmaceutical Executive

Gilead Subsidiary Kite to Acquire Interius BioTherapeutics for $350 Million Pharmaceutical Executive

Roundup: Pharma Giants Expand Strategic Pipelines Through Targeted M&A and Partnerships Pharmaceutical Executive

Merck Begins Construction on $1 Billion Biologics Manufacturing Hub Pharmaceutical Executive